SK283701B6 - Spôsob prípravy pastiliek s obsahom flurbiprofénu - Google Patents

Spôsob prípravy pastiliek s obsahom flurbiprofénu Download PDF

Info

Publication number
SK283701B6
SK283701B6 SK1588-99A SK158899A SK283701B6 SK 283701 B6 SK283701 B6 SK 283701B6 SK 158899 A SK158899 A SK 158899A SK 283701 B6 SK283701 B6 SK 283701B6
Authority
SK
Slovakia
Prior art keywords
lozenge
flurbiprofen
mixture
lozenges
granules
Prior art date
Application number
SK1588-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK158899A3 (en
Inventor
Andrew Day
Huw Lyn Jones
Carl Simon Smith
Original Assignee
The Boots Company Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company Plc filed Critical The Boots Company Plc
Publication of SK158899A3 publication Critical patent/SK158899A3/sk
Publication of SK283701B6 publication Critical patent/SK283701B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1588-99A 1997-05-22 1998-05-20 Spôsob prípravy pastiliek s obsahom flurbiprofénu SK283701B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process
PCT/EP1998/003167 WO1998052539A1 (en) 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges

Publications (2)

Publication Number Publication Date
SK158899A3 SK158899A3 (en) 2000-05-16
SK283701B6 true SK283701B6 (sk) 2003-12-02

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1588-99A SK283701B6 (sk) 1997-05-22 1998-05-20 Spôsob prípravy pastiliek s obsahom flurbiprofénu

Country Status (31)

Country Link
US (1) US6194003B1 (pt)
EP (1) EP0983059B1 (pt)
JP (1) JP2001527567A (pt)
KR (1) KR20010012739A (pt)
CN (1) CN1154480C (pt)
AR (1) AR015812A1 (pt)
AT (1) ATE245021T1 (pt)
AU (1) AU725760B2 (pt)
BG (1) BG103881A (pt)
BR (1) BR9809651A (pt)
CA (1) CA2290830C (pt)
CZ (1) CZ290816B6 (pt)
DE (1) DE69816440T2 (pt)
DK (1) DK0983059T3 (pt)
ES (1) ES2202871T3 (pt)
GB (1) GB9710521D0 (pt)
HU (1) HU224954B1 (pt)
ID (1) ID22949A (pt)
IL (1) IL132999A0 (pt)
IN (1) IN187837B (pt)
MY (1) MY118410A (pt)
NO (1) NO995681L (pt)
NZ (1) NZ500664A (pt)
PL (1) PL190947B1 (pt)
PT (1) PT983059E (pt)
RU (1) RU2203046C2 (pt)
SK (1) SK283701B6 (pt)
TR (1) TR199902725T2 (pt)
UA (1) UA53714C2 (pt)
WO (1) WO1998052539A1 (pt)
ZA (1) ZA984260B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE324868T1 (de) 1999-12-09 2006-06-15 Boots Co Plc Komprimierte zubereitung enthaltend nichtsteroidale entzündungshemmer
CA2406383A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research A.beta.42 lowering agents
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
WO2005065069A2 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
EP1745180A1 (en) * 2004-04-29 2007-01-24 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006082501A2 (en) 2005-02-03 2006-08-10 Nycomed Pharma As Fast wet-massing method for the preparation of calcium-containing compositions
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
US20070042034A1 (en) * 2005-07-22 2007-02-22 Myriad Genetics, Incorporated High drug load formulations and dosage forms
AU2006312119B2 (en) * 2005-11-02 2010-04-29 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
KR20100020449A (ko) * 2007-07-23 2010-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 기호적으로 허용될 수 있는 인돌 세로토닌 수용체 작용제 경구 투여 제제 및 이를 사용하는 방법
BRPI0917191A2 (pt) * 2008-08-22 2015-11-10 Reckitt Benckiser Healthcare aperfeiçoamentos em ou relacionados a composições
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
LT2701681T (lt) 2011-04-29 2016-12-12 Moberg Pharma Ab Farmacinės kompozicijos, apimančios vietinį anestetiką, tokį kaip bupivakainas, skirts vietiniam įvedimui į burną arba į gerklę
EP2609911A1 (en) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. A novel process for preparing orally disintegrating flurbiprofen formulations
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
US20180228832A1 (en) * 2015-08-18 2018-08-16 Pharma Seeds Create, Llc Stomatological composition containing nsaid or heparin compound
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
IT1243342B (it) 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
US5302394A (en) 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
AR015812A1 (es) 2001-05-30
CZ290816B6 (cs) 2002-10-16
HUP0002121A3 (en) 2001-04-28
DE69816440T2 (de) 2004-05-13
TR199902725T2 (xx) 2000-02-21
ATE245021T1 (de) 2003-08-15
CN1154480C (zh) 2004-06-23
UA53714C2 (uk) 2003-02-17
RU2203046C2 (ru) 2003-04-27
CA2290830A1 (en) 1998-11-26
JP2001527567A (ja) 2001-12-25
NZ500664A (en) 2001-01-26
PL336624A1 (en) 2000-07-03
GB9710521D0 (en) 1997-07-16
US6194003B1 (en) 2001-02-27
MY118410A (en) 2004-10-30
IL132999A0 (en) 2001-03-19
NO995681D0 (no) 1999-11-19
DK0983059T3 (da) 2003-11-03
ES2202871T3 (es) 2004-04-01
BG103881A (en) 2000-05-31
KR20010012739A (ko) 2001-02-26
EP0983059B1 (en) 2003-07-16
CA2290830C (en) 2006-07-11
SK158899A3 (en) 2000-05-16
WO1998052539A1 (en) 1998-11-26
PT983059E (pt) 2003-11-28
IN187837B (pt) 2002-06-29
EP0983059A1 (en) 2000-03-08
DE69816440D1 (de) 2003-08-21
ID22949A (id) 1999-12-16
BR9809651A (pt) 2000-07-11
ZA984260B (en) 1999-02-20
CN1255848A (zh) 2000-06-07
AU7916598A (en) 1998-12-11
CZ412099A3 (cs) 2000-02-16
HUP0002121A2 (hu) 2000-12-28
NO995681L (no) 1999-11-19
AU725760B2 (en) 2000-10-19
PL190947B1 (pl) 2006-02-28
HU224954B1 (en) 2006-04-28

Similar Documents

Publication Publication Date Title
SK283701B6 (sk) Spôsob prípravy pastiliek s obsahom flurbiprofénu
RU2203655C2 (ru) Средство и способ облегчения симптомов больного горла
WO1998052545A1 (en) Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
HU221614B (hu) Nem-szteroid analgetikumok átlátszó, gyors hatóanyag-kibocsátású készítményei és eljárás előállításukra
JP2007517011A (ja) 経口デリバリーのための多粒子製剤
WO1998052540A1 (en) Pharmaceutical compositions
US20190307711A1 (en) Production Process For Nsaid-Containing Lozenges, Their Compositions, Their Medicinal Use
ES2369137T3 (es) Formulación que comprende granulos de masa fundida de aine y ácidos orgánicos.
MXPA99010548A (en) Process for making flurbiprofen lozenges
PL237530B1 (pl) Przeciwbólowo-przeciwzapalna kompozycja farmaceutyczna podawana miejscowo do stosowania w leczeniu gorączki i/lub bólu, zwłaszcza do stosowania w stanach zapalnych jamy ustnej i gardła
D Sree Formulation And Evaluation Of Fast Dissolving Tablets Of Amlodipine Besylate

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20090520